Katrijn Grupping

Summary

Affiliation: Institute of Tropical Medicine
Country: Belgium

Publications

  1. pmc MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency
    Katrijn Grupping
    Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine of Antwerp, Antwerp, Belgium
    Retrovirology 9:36. 2012
  2. pmc Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011
    Nicolas Ruffin
    Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
    J Transl Med 10:144. 2012
  3. pmc Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference
    Britta Wahren
    Karolinska Institute, Stockholm, Sweden
    J Transl Med 8:72. 2010
  4. doi HIV type 1 subtype A envelope genetic evolution in a slow progressing individual with consistent broadly neutralizing antibodies
    Tessa Dieltjens
    Department of Microbiology, Unit of Virology, Institute of Tropical Medicine, Antwerp, Belgium
    AIDS Res Hum Retroviruses 25:1165-9. 2009
  5. pmc In vitro activities of candidate microbicides against cell-associated HIV
    Philippe Selhorst
    Virology Unit, Institute of Tropical Medicine, Antwerp, Belgium
    Antimicrob Agents Chemother 56:805-15. 2012
  6. pmc M48U1 CD4 mimetic has a sustained inhibitory effect on cell-associated HIV-1 by attenuating virion infectivity through gp120 shedding
    Philippe Selhorst
    Department of Biomedical Sciences, Unit of Virology, Institute of Tropical Medicine, Antwerp, B 2000, Belgium
    Retrovirology 10:12. 2013
  7. pmc Evolution of antibody landscape and viral envelope escape in an HIV-1 CRF02_AG infected patient with 4E10-like antibodies
    Tessa Dieltjens
    Department of Microbiology, Unit of Virology, Institute of Tropical Medicine, Antwerp, Belgium
    Retrovirology 6:113. 2009

Collaborators

Detail Information

Publications7

  1. pmc MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency
    Katrijn Grupping
    Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine of Antwerp, Antwerp, Belgium
    Retrovirology 9:36. 2012
    ..The miniCD4 proteins are a promising class of CD4bs inhibitors. Studying virus evolution under pressure of CD4bs inhibitors could provide insight on the gp120-CD4 interaction and viral entry...
  2. pmc Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011
    Nicolas Ruffin
    Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
    J Transl Med 10:144. 2012
    ..These - necessarily overlapping topics - are comprehensively summarised by the Europrise students in the context of other recent exciting data...
  3. pmc Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference
    Britta Wahren
    Karolinska Institute, Stockholm, Sweden
    J Transl Med 8:72. 2010
    ..Since training is a major task of the Network, the students of the EUROPRISE PhD program summarized certain presentations and their view of the conference in this paper...
  4. doi HIV type 1 subtype A envelope genetic evolution in a slow progressing individual with consistent broadly neutralizing antibodies
    Tessa Dieltjens
    Department of Microbiology, Unit of Virology, Institute of Tropical Medicine, Antwerp, Belgium
    AIDS Res Hum Retroviruses 25:1165-9. 2009
    ..Conservation of functional epitopes may correlate with the continued presence of broad cross-neutralizing antibodies...
  5. pmc In vitro activities of candidate microbicides against cell-associated HIV
    Philippe Selhorst
    Virology Unit, Institute of Tropical Medicine, Antwerp, Belgium
    Antimicrob Agents Chemother 56:805-15. 2012
    ..Overall, these results show that entry and protease inhibitors are eligible drug classes for inclusion in future combination microbicides...
  6. pmc M48U1 CD4 mimetic has a sustained inhibitory effect on cell-associated HIV-1 by attenuating virion infectivity through gp120 shedding
    Philippe Selhorst
    Department of Biomedical Sciences, Unit of Virology, Institute of Tropical Medicine, Antwerp, B 2000, Belgium
    Retrovirology 10:12. 2013
    ..HIV-1 infected cells can establish new infections by crossing the vaginal epithelia and subsequently producing virus in a milieu that avoids the high microbicide concentrations of the vaginal lumen...
  7. pmc Evolution of antibody landscape and viral envelope escape in an HIV-1 CRF02_AG infected patient with 4E10-like antibodies
    Tessa Dieltjens
    Department of Microbiology, Unit of Virology, Institute of Tropical Medicine, Antwerp, Belgium
    Retrovirology 6:113. 2009
    ..This study also aimed to use the selected mimotopes as tools to unravel the evolution of the antibody landscape and the viral envelope escape which may provide us with new insights for vaccine design...